Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study

1997, A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project, Blood, 89, 3909, 10.1182/blood.V89.11.3909

JR Anderson, 1998, Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project, Ann Oncol, 9, 717, 10.1023/A:1008265532487

E Bachy, 2013, Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma, Haematologica, 98, 1107, 10.3324/haematol.2012.082412

D Tan, 2013, Improvements in observed and relative survival in follicular grade 1–2 lymphoma during 4 decades: the Stanford University experience, Blood, 122, 981, 10.1182/blood-2013-03-491514

HR Junlen, 2014, Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women—a Swedish Lymphoma Registry study, Leukemia, 29, 668, 10.1038/leu.2014.251

S Montoto, 2007, Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma, J Clin Oncol, 25, 2426, 10.1200/JCO.2006.09.3260

AJ Al-Tourah, 2008, Population-based analysis of incidence and outcome of transformed non-Hodgkin’s lymphoma, J Clin Oncol, 26, 5165, 10.1200/JCO.2008.16.0283

BK Link, 2013, Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource, J Clin Oncol, 31, 3272, 10.1200/JCO.2012.48.3990

L Mozessohn, 2014, Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis, Leuk Lymphoma, 55, 2502, 10.3109/10428194.2014.885513

C Casulo, 2015, Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study, J Clin Oncol, 33, 2516, 10.1200/JCO.2014.59.7534

K Lerch, 2015, Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis, Ann Hematol, 94, 981, 10.1007/s00277-015-2303-5

ND Wagner-Johnston, 2015, Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS), Blood, 126, 851, 10.1182/blood-2015-01-621375

V Jurinovic, 2016, Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy, Blood, 128, 1112, 10.1182/blood-2016-05-717355

L Ding, 2012, Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing, Nature, 481, 506, 10.1038/nature10738

Landau Da, 2013, Evolution and impact of subclonal mutations in chronic lymphocytic leukemia, Cell, 152, 714, 10.1016/j.cell.2013.01.019

DA Landau, 2015, Mutations driving CLL and their evolution in progression and relapse, Nature, 526, 525, 10.1038/nature15395

AS Morrissy, 2016, Divergent clonal selection dominates medulloblastoma at recurrence, Nature, 529, 351, 10.1038/nature16478

MJ Walter, 2012, Clonal architecture of secondary acute myeloid leukemia, N Engl J Med, 366, 1090, 10.1056/NEJMoa1106968

G Fabbri, 2013, Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome, J Exp Med, 210, 2273, 10.1084/jem.20131448

J Okosun, 2014, Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma, Nat Genet, 46, 176, 10.1038/ng.2856

L Pasqualucci, 2014, Genetics of follicular lymphoma transformation, Cell Rep, 6, 130, 10.1016/j.celrep.2013.12.027

T Yano, 1992, MYC rearrangements in histologically progressed follicular lymphomas, Blood, 80, 758, 10.1182/blood.V80.3.758.758

IS Lossos, 2002, Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes, Proc Natl Acad Sci U S A, 99, 8886, 10.1073/pnas.132253599

F Lo Coco, 1993, p53 mutations are associated with histologic transformation of follicular lymphoma, Blood, 82, 2289, 10.1182/blood.V82.8.2289.2289

CA Sander, 1993, p53 mutation is associated with progression in follicular lymphomas, Blood, 82, 1994, 10.1182/blood.V82.7.1994.1994

J Fitzgibbon, 2007, Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma, Leukemia, 21, 1514, 10.1038/sj.leu.2404696

AJ Davies, 2007, Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms, Br J Haematol, 136, 286, 10.1111/j.1365-2141.2006.06439.x

E Carlotti, 2009, Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone, Blood, 113, 3553, 10.1182/blood-2008-08-174839

D O’Shea, 2009, Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation, Blood, 113, 2298, 10.1182/blood-2008-08-174953

JJ Yunis, 1987, Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer, N Engl J Med, 316, 79, 10.1056/NEJM198701083160204

H Tilly, 1994, Prognostic value of chromosomal abnormalities in follicular lymphoma, Blood, 84, 1043, 10.1182/blood.V84.4.1043.1043

M Höglund, 2004, Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas, Genes Chromosomes Cancer, 39, 195, 10.1002/gcc.10314

D O’Shea, 2008, The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival, Blood, 112, 3126, 10.1182/blood-2008-05-154013

F D’Amore, 2008, Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution, Clin Cancer Res, 14, 7180, 10.1158/1078-0432.CCR-08-0752

KJJ Cheung, 2009, Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances, Blood, 113, 137, 10.1182/blood-2008-02-140616

A Alhejaily, 2014, Inactivation of the CDKN2A tumor suppressor gene by deletion or methylation is common at diagnosis in follicular lymphoma and associated with poor clinical outcome, Clin Cancer Res, 20, 1676, 10.1158/1078-0432.CCR-13-2175

A Pastore, 2015, Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry, Lancet Oncol, 2045, 1

A Roth, 2014, PyClone: statistical inference of clonal population structure in cancer, Nat Methods, 11, 396, 10.1038/nmeth.2883

S Malikic, 2015, Clonality inference in multiple tumor samples using phylogeny, Bioinformatics, 31, 1349, 10.1093/bioinformatics/btv003

JR Muppidi, 2014, Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma, Nature, 516, 254, 10.1038/nature13765

S Schiffels, 2011, Emergent neutrality in adaptive asexual evolution, Genetics, 189, 1361, 10.1534/genetics.111.132027

C Curtis, 2012, The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, 486, 346, 10.1038/nature10983

MR Green, 2010, Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma, Blood, 116, 3268, 10.1182/blood-2010-05-282780